Home > Products > CD3 & CEA
> Recombinant Anti-CD3 x Anti-CEA VHH BispecificAntibody (IgG-VHH)
Recombinant Anti-CD3 x Anti-CEA VHH BispecificAntibody (IgG-VHH) (CAT#: IGVHH-018)
Recombinant Anti-CD3 x Anti-CEA Bispecific Antibody (IgG-VHH) is designed to be expressed as a LC and an extended HC with VHH moiety linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb can retarget T cells to tumor cells. It is designed for the research of Colorectal cancer (CRC); Breast cancer; Lung cancer; Gastric cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-CEA VHH BispecificAntibody (IgG-VHH) (IGVHH-018). Click the button below to contact us or submit your feedback about this product.